140 related articles for article (PubMed ID: 29322188)
1. Management of Morgellons Disease With Low-Dose Trifluoperazine.
Yan BY; Jorizzo JL
JAMA Dermatol; 2018 Feb; 154(2):216-218. PubMed ID: 29322188
[TBL] [Abstract][Full Text] [Related]
2. Morgellons disease treatment with quetiapine.
Carrillo de Albornoz Calahorro CM; López-Delgado D; Gutiérrez-Rojas L
Med Clin (Barc); 2019 Feb; 152(3):118-119. PubMed ID: 29706457
[No Abstract] [Full Text] [Related]
3. Morgellons disease etiology and therapeutic approach: a systematic review.
Beuerlein KG; Balogh EA; Feldman SR
Dermatol Online J; 2021 Aug; 27(8):. PubMed ID: 34755952
[TBL] [Abstract][Full Text] [Related]
4. Morgellons disease: insights into treatment.
Aung-Din D; Sahni DR; Jorizzo JL; Feldman SR
Dermatol Online J; 2018 Nov; 24(11):. PubMed ID: 30695970
[TBL] [Abstract][Full Text] [Related]
5. Morgellons disease, or antipsychotic-responsive delusional parasitosis, in an HIV patient: beliefs in the age of the Internet.
Freudenreich O; Kontos N; Tranulis C; Cather C
Psychosomatics; 2010; 51(6):453-7. PubMed ID: 21051675
[No Abstract] [Full Text] [Related]
6. Disorder or delusion? Living with Morgellons disease.
Simpson L; Baier M
J Psychosoc Nurs Ment Health Serv; 2009 Aug; 47(8):36-41. PubMed ID: 19681520
[TBL] [Abstract][Full Text] [Related]
7. Morgellons disease: experiences of an integrated multidisciplinary dermatology team to achieve positive outcomes.
Mohandas P; Bewley A; Taylor R
J Dermatolog Treat; 2018 Mar; 29(2):208-213. PubMed ID: 28665169
[TBL] [Abstract][Full Text] [Related]
8. Variable clinical presentations of secondary delusional infestation: an experience of six cases from a psychodermatology clinic.
Altunay IK; Ates B; Mercan S; Demirci GT; Kayaoglu S
Int J Psychiatry Med; 2012; 44(4):335-50. PubMed ID: 23885516
[TBL] [Abstract][Full Text] [Related]
9. Morgellons in dermatology.
Harth W; Hermes B; Freudenmann RW
J Dtsch Dermatol Ges; 2010 Apr; 8(4):234-42. PubMed ID: 19878403
[TBL] [Abstract][Full Text] [Related]
10. The challenge of Morgellons disease: A patient with clinicopathologic correlation.
Caputo V; Bonoldi E; Citterio A; Rongioletti F
Clin Dermatol; 2022; 40(6):686-690. PubMed ID: 35905899
[TBL] [Abstract][Full Text] [Related]
11. [Morgellons syndrome: a disease transmitted via the media].
Misery L
Ann Dermatol Venereol; 2013 Jan; 140(1):59-62. PubMed ID: 23328363
[No Abstract] [Full Text] [Related]
12. Psychosis, ivermectin toxicity, and "Morgellons disease".
DeBonis K; Pierre JM
Psychosomatics; 2011; 52(3):295-6. PubMed ID: 21565604
[No Abstract] [Full Text] [Related]
13. Delusional Infestation: State of the Art.
Vulink NC
Acta Derm Venereol; 2016 Aug; 96(217):58-63. PubMed ID: 27282746
[TBL] [Abstract][Full Text] [Related]
14. Morgellons: contested illness, diagnostic compromise and medicalisation.
Fair B
Sociol Health Illn; 2010 May; 32(4):597-612. PubMed ID: 20149149
[TBL] [Abstract][Full Text] [Related]
15. Choosing the appropriate pharmacotherapy for Morgellons disease: an expert perspective.
Balogh EA; Beuerlein KG; Feldman SR
Expert Opin Pharmacother; 2022 Apr; 23(5):527-530. PubMed ID: 35076344
[No Abstract] [Full Text] [Related]
16. Delusional parasitosis facilitated by web-based dissemination.
Vila-Rodriguez F; Macewan BG
Am J Psychiatry; 2008 Dec; 165(12):1612. PubMed ID: 19047336
[No Abstract] [Full Text] [Related]
17. Successful treatment of Morgellons disease with pimozide therapy.
Reid EE; Lio PA
Arch Dermatol; 2010 Oct; 146(10):1191-3. PubMed ID: 20956673
[No Abstract] [Full Text] [Related]
18. Intravenous immunoglobulin for refractory cutaneous dermatomyositis: a retrospective analysis from an academic medical center.
Femia AN; Eastham AB; Lam C; Merola JF; Qureshi AA; Vleugels RA
J Am Acad Dermatol; 2013 Oct; 69(4):654-7. PubMed ID: 24034377
[No Abstract] [Full Text] [Related]
19. The quinacrine experience in a population of patients with cutaneous lupus erythematosus and dermatomyositis.
Mittal L; Werth VP
J Am Acad Dermatol; 2017 Aug; 77(2):374-377. PubMed ID: 28711090
[No Abstract] [Full Text] [Related]
20. Rapid improvement of prurigo nodularis with cyclosporine treatment.
Wiznia LE; Callahan SW; Cohen DE; Orlow SJ
J Am Acad Dermatol; 2018 Jun; 78(6):1209-1211. PubMed ID: 29438756
[No Abstract] [Full Text] [Related]
[Next] [New Search]
